Increased renal phosphate wasting, mild hypophosphatemia, increased 1,25(OH)2D and hypercalciuria without metabolic bone disease, can be present in patients with heterozygous SLC34A3 mutations, indicating haploinsufficiency (124). Here, SLC34A3 is linked to Hypercalciuria.